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Summary
Objective. Nitric oxide (NO) is a free radical molecule endogenously produced by NO synthases that may play a critical
role in inflammation. It inhibits cell proliferation and may be involved in the induction of apoptosis in various cellular
models. Recently, the presence of apoptotic cells was reported in the synovium of osteoarthritic (OA) patients. The aim
of this study was to determine whether synovial fibroblasts are target cells for NO-induced apoptosis. The expression
of p53 protein was also studied to evaluate the ability of synovial cells to repair DNA fragmentation.
Methods. Synoviocytes from OA patients were treated with two NO donors: sodium nitroprusside (SNP) and
S-nitroso-N-acetyl-penicillamine (SNAP). Apoptosis was analysed by transmission electron microscopy. DNA content
was evaluated by flow cytometric analysis after propidium iodide staining and recognition of DNA strand break
determined by the TUNEL (TdT-mediated dUTP nick end labeling) method. P53 protein expression was studied by
immunofluorescence using a monoclonal antibody.
Results. After 6 hours, cells treated with NO donors (1.25 mM) showed a cytoplasmic condensation and vacuoliz-
ation. DNA strand break analysis by the TUNEL method confirmed the presence of a DNA fragmentation after 24
hours of NO treatment. There was also a progressive decrease in the DNA diploid peak in response to NO donors. In
parallel, p53 protein, constitutively expressed in cytoplasmic synovial cells, showed markedly increased expression
after a 6-hour NO exposure and displayed prominent nuclear staining after 12 hours.
Conclusions. This study demonstrates the potential role of NO for the induction of synoviocyte apoptosis in OA. The
increased expression of p53 in the nucleus may play a protective role in the control of apoptosis.
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OSTEOARTHRITIS (OA) is characterized by morpho-
logical and quantitative alterations of articular
cartilage leading to its destruction. The early
changes in osteoarthritic joints seem partly to
involve the synovial membrane as observed in
experimental models [1]. Synovial membrane in
OA exhibits morphological changes and early
increase in enzymatic activity [2]. Moreover, syn-
ovial inflammation is often observed during the
flares of the disease and probably plays an import-
ant role in the pathogenesis of OA [3]. Previous
studies have shown that synovitis may be promi-
nent next to areas of severe cartilage lesions [4].
Synoviocytes in OA produce metalloproteases and
proinflammatory cytokines such as interleukin-1â203(IL-1â), tumor necrosis factor Æ (TNF-Æ) and
interleukin-6 (IL-6) [5–6], which exert a negative
e#ect on cartilage turnover. Synovial membrane
is exposed very early to the aggressive factors
contained in the synovial fluid.
Apoptosis is characterized by nuclear chromatin
condensation and DNA digestion into nucleosome-
sized fragments. Several proteins can regulate the
apoptosis such as the p53 tumor suppressor that
increases in response to DNA damage. P53 serves
as a regulator of cell survival and proliferation
and regulates a variety of DNA repairs [7].
Nitric oxide (NO) is considered as an extracellu-
lar messenger. It can di#use very rapidly and acts
on other neighboring cells. Also, it has been shown
that NO inhibits cell proliferation and can induce
apoptosis in other cell models such as murine
macrophages [8] or mouse thymocytes [9].
Recently, human chondrocytes and rabbit synovio-
cytes were found to synthesize substantial
amounts of NO in response to IL-1â [10–12].
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gested by the report of substantial concentrations
of metabolites of NO in human OA synovial fluids,
such as nitrite, nitrate, and nitrosoproteins
[13–15]. Chondrocytes in OA are able to produce
high amounts of NO. Moreover, it was shown that
larger amounts of NO may be produced by super-
ficial chondrocytes than by their deep counter-
parts [16]. In addition, Blanco et al. [17] have
shown NO involvement in the induction of cell
death in human OA chondrocytes. The presence of
apoptotic cells has been reported in the synovial
membrane in RA as well as in OA. Apoptosis could
thus serve as a regulatory process to control
synovial cell metabolism in OA [18–19].
This study aimed to investigate the potential
role of NO in the modulation of apoptosis of
synoviocytes in OA. We show that apoptosis,
assessed by several independent methods, can be
regulated by high-dose NO donors despite p53
overexpression.Materials and methodsREAGENTS
Reagents were: Dulbecco’s Minimal Essential
Medium (DMEM), Phosphate bu#ered saline (PBS)
(Gibco, Grand Island, NY); fetal calf serum (FCS)
(Biowittaker Walkerville, MD), sodium nitro-
prussiate (SNP), S-nitroso-N-acetyl-penicillamine
(SNAP), collagenase type I, trypsine, RNAse A,
bovine serum albumin (BSA), oxyhemoglobin,
sodium nitrite, sulfanilamide, N-1-naphthyl-
ethylenediamide dihydrochloride, Nicotinamide
Adenine dinucleotide reduced form (NADH),
pyruvate, paraformaldehyde, glutaraldehyde, Tris
base, osmium tetroxide, lead citrate, N-Methyl-
Arginine (NMA), (Sigma Chemical Co. St Louis,
MO), in-situ fluorescein cell death detection
kit (Boehringer Mannheim Biochemicals,
Indianapolis, IN) propidium iodide (Becton
Dickinson Mountain View CA), p53 polyclonal
antibody (Biosys SA, France), fluorescein conju-
gated anti-rabbit IgG antibody (Amersham Corp.,
Arlington Heights, IL), monoclonal biotinyled
anti-rabbit IgG antibody, streptavidine-rhodamine
system (Vector Laboratories, Inc, Burlingame,
CA).
All recombinant cytokines were purchased from
Genzyme Corp., Cambridge,MA.SYNOVIOCYTE ISOLATION AND CULTURE
Human synovial cells from eight patients with
OA of the hip (seven females and one male, meanage 62&12 years) were isolated from synovium
obtained during joint surgery. After dissection, the
superficial layer of synovium was digested with
collagenase and trypsin as previously described
[20], Cells were suspended in DMEM containing
10% FCS, amphotericin B, netromycin, ceftazidim,
vancomycin and cultured at 5#106 cells in 75 cm2
culture flasks at 37)C in a humidified incubator
with an atmosphere containing 5% CO2. After
overnight cultured, nonadherent cells were
removed and adherent cells were cultured in
DMEM plus 10% FCS. When confluence was
attained, cells were trypsinized and cultured on
glass slides placed in 9.6 cm2 plates (2#105 cells
per well) or in 75 cm2 culture flasks (1#106 cells
per flask) at 37)C (5% CO2). Experiments were
performed on confluent cultures at first passage.EVALUATION OF MORPHOLOGICAL CELLULAR CHANGES
To identify morphological changes induced by
NO donors, synoviocytes were examined using a
phase contrast microscope. Cells displaying apop-
totic changes were identified using previously
defined morphological criteria including chroma-
tin condensation, nuclear fragmentation, and
blebbing of cytoplasmic membrane [21–22].RECOGNITION OF DNA STRAND BREAKS BY THE TERMINAL
DEOXYNUCLEOTIDYL TRANSFERASE MEDIATED dUTP
NICK-END LABELING (TUNEL) METHOD
To estimate the percentage of synovial cells
undergoing apoptosis, cells containing DNA
strand breaks were visualized by the TUNEL
method as described by Gavrieli et al. [23] with an
in-situ fluorescein cell death detection kit accord-
ing to the recommendations of the manufacturer.
Briefly, cells on slides were washed in PBS and
fixed with 4% paraformaldehyde for 10 minutes
and then incubated for 1 h with fluorescein labeled
dUTP and deoxytransferase. After washing, the
slides were examined by fluorescence microscopy
(#100). Controls consisted of omission of the de-
oxytransferase from the labeling reaction. Quanti-
fication of data was obtained by examination of a
defined area of each plate. The number of cells with
apoptotic nuclei and total cell numbers per field
were determined by two independent observers
and used for statistical analysis as previously
described [24]. To assess the specific e#ect of NO
aggression on DNA, cells were co-treated with
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scavanger of NO.TRANSMISSION ELECTRON MICROSCOPY
For electron microscopy, first passage synovio-
cytes were grown as monolayers in 75 cm2 flasks.
At confluence, cells received 1.25 mM SNP or
SNAP for the times indicated below. They were
fixated in 2.5% glutaraldehyde bu#ered in PBS
then scraped, pelleted, rinsed with PBS, fixed for
1 h at room temperature with PBS, post-fixed for
1 h in 2% osmium tetroxide bu#ered with PBS,
dehydrated in a graded ethanol series and embed-
ded in Epon resin. Thin sections of cell pelletswere stained with 2% uranyl acetate in ethanol
and lead citrate.FIG. 1. Analysis of synovial cells by phase contrast microscopy. A: untreated cells at confluence, B: SNP (1.25 mM) for
12 hours: morphological changes consistent with apoptosis. Arrows show plasma membrane blebbing. Magnification
#400.FLOW CYTOMETRY OF DNA CONTENT
Nuclear DNA content was analysed by flow
cytometry after iodide propidium staining using
the method described by Vindelov et al. [25].
Briefly, cells were centrifuged at 400#g for 5
minutes at room temperature and trypsinized
(0.3 mg/ml) in a citrate bu#er pH 7.6, 0.4 mM. They
were then incubated with RNAse A (0.4 mg/ml) for
15 minutes at +4)C in the dark. After filtering the
samples through 50 ìm nylon mesh, propidium
iodide fluorescence of nuclei was measured on a
206 D. Borderie et al.: Nitric oxide induces synoviocyte apoptosisFACScan instrument (Becton Dickinson Moun-
tain View CA) with a 560 nm dichromatic mirror
and a 600 nm band pan filter. Results were ana-
lyzed by CellFIT software on the FACScan flow
cytometer.IMMUNOFLUORESCENCE STUDY OF P53 EXPRESSION
After treatment by NO donors, cells on glass
slides were fixed and permeabilized with an
acetone/methanol mixture (V/V) at "20)C for 10
minutes and then rehydrated in PBS plus 1% BSA.
The slides were preincubated with 10% goat serum
for 30 minutes and then incubated 1 hour at +37)C
with the p53 rabbit polyclonal antibody diluted in
PBS plus 1% BSA to 1/500 or normal rabbit Ig as a
negative control. The slides were then incubated
with a fluorescein conjugated anti-rabbit IgG
antibody diluted in PBS to 1/100.
For co-localization studies of DNA strand break
and p53 expression, slides were first processed for
the TUNEL method as described, followed by p53
detection using a biotinylated second antibody
diluted to 1/100. Visualization was performedusing a streptavidin/rhodamine system. Quantifi-
cation of data was obtained by examination of
defined area on each slide. Numbers of TUNEL
and/or p53-positive cells and total cell numbers
per field were determined by two independent
observers and were used for statistical analysis as
previously described [26].FIG. 2. Electron micrographs of cultured synovial cells. A: untreated cells, B: after treatment by SNP (1.25 mM) for
3 hours: vacuolization of the cytoplasm; C: after treatment by SNP (1.25 mM) for 6 hours: important vacuolization and
condensation of the cytoplasm; D: detail of the cytoplasmic membrane: blebbing of the cytoplasmic membrane,
disorganization of the Golgi apparatus. Bar equals 2 ìm A–C, and 0.5 ìm D.QUANTIFICATION OF NITRITE
NO formation was detected by nitrite accumu-
lation in the cultured cell supernatants by the
diazotization reaction of Griess with sodium nitrite
as standard [27]. Briefly, 100 ìl of culture super-
natant were incubated with 100 ìl of 1% sulfa-
nilamide, 0.1% N-1-naphthylethylenediamide
dihydrochloride in 25% H3PO4 at room tempera-
ture for 10 minutes. Optical densities were
measured at 570 nanometers using a Dynatech MR
5000 microplate reader (Dynex Technology S.A.,
France). Background levels of nitrite were deter-
mined in the cell-free DMEM with or without addi-
tives and were subtracted from the total amount
of nitrite formed. The nitrite concentration was
Osteoarthritis and Cartilage Vol. 7 No. 2 207calculated from a NaNO2 standard curve. The
detection limit for nitrite was 1 ìmol/ml.DATA PRESENTATION AND STATISTICAL ANALYSIS
All experiments were repeated at least three
times. The microphotographs are representative of
the results obtained in these experiments. The
quantitative data are the mean values&1 standard
deviation (S.D.) from representative experiments
performed in triplicate. Statistical significance
was evaluated by Wilcoxon’s signed rank test.ResultsFIG. 3. DNA fragmentation analysed by the TUNEL method. A: untreated cells, B: cells treated for 24 hours by SNP or
SNAP (1.25 mM). Magnification #1000.NO DONORS INDUCE MORPHOLOGICAL APOPTOTIC CHANGES
When NO was applied through SNP (1.25 mM),
apoptosis was observed at the first passage byphase contrast microscopy. After 6 hours, cells
started to change morphology, became rounded
and started to detach from dishes. At 12 hours,
cells showed cytoplasmic condensation and
blebbing of the cytoplasmic membrane (Fig. 1).
To confirm these data, cells treated with NO
donors were examined by electron microscopy
after 0, 3 and 6 hours. The micrograph in Fig. 2
shows the changes at the 3rd hour, including
cytoplasmic condensation; at this time we
observed the persistence of a continuous plasma
membrane and the protuberances on the cell sur-
face that precede the shedding of apoptotic bodies.
Later at the 6th hour, treated cells showed a
paucity of cytoplasmic organelles and a digitiza-
tion of the plasmalemma, ribosomes were not well
individuated and the reticules showed a large
208 D. Borderie et al.: Nitric oxide induces synoviocyte apoptosisnumber of small dilated saccules. At the same time,
a vacuolization in the cytoplam appeared. All
these events seemed to precede the chromatin
condensation.
The overall e#ects of SNAP were similar at the
same concentration (1.25 mM) but the time course
was di#erent: the e#ect was faster with SNP than
with SNAP. After 12 hours, a higher proportion of
apoptotic cells was observed with SNP than with
SNAP (SNP 69&3% versus SNAP 52&2%).DNA ALTERATION ANALYSIS
To confirm that NO can induce apoptosis in
synoviocytes, cells were treated with 0.01 to
1.25 mM SNP or SNAP. The DNA fragmentation
was analysed by the TUNEL method. This tech-
nique allows detection of DNA strand breaks by
means of their 3*-OH extremities.
Under normal conditions of culture, cells
showed no fluorescence staining. After incubation
with NO donors, there was a dose and time-
dependent increase in nuclear binding which was
maximal after 24 hours (Fig. 3). This NO e#ect was
inhibited when cells were co-incubated with NO
donors and oxyhemoglobin (Table I).
To follow the kinetics of these changes, cells
were analysed by flow cytometry after staining
with propidium iodide. In response to treatment
with 1.25 mM SNP or SNAP, there was a progress-
ive decrease in the diploid peak and an increase in
the number of hypoploid cells as shown in Fig. 4.
The e#ects of the NO donors were observed fromthe 6th hour. At 12 hours, the flow analysis showed
a complete DNA breakdown.Table I
Dose-effects of two NO donors for the induction of synoviocyte apoptosis
% of apoptotic cells
T=6 hours
% of apoptotic cells
T=24 hours
Without
oxyhemoglobin
With
oxyhemoglobin
(100 ìmol/l)
Without
oxyhemoglobin
With
oxyhemoglobin
(100 ìmol/l)
Control <1 <1 <1 <1
SNP 0.01 mmol/l <1 <1 1 <1
SNP 0.1 mmol/l <1 <1 15&2 <1
SNP 0.5 mmol/l 20&2 <1 40&7 5&2
SNP 1 mmol/l 45&7 5&1 85&8 10&2
SNP 1.25 mmol/l 48&5 5&2 90&10 12&3
SNAP 0.01 mmol/l <1 <1 <1 <1
SNAP 0.1 mmol/l <1 <1 10&1 <1
SNAP 0.5 mmol/l 20&2 <1 18&6 4&2
SNAP 1 mmol/l 38&7 4&2 50&8 7&3
SNAP 1.25 mmol/l 45&9 3&2 70&10 7&5
Cultured synovial cells from OA patients were treated with di#erent concentrations of two NO donors,
SNP (sodium nitroprussiate) and SNAP (S-nitroso-N-acetyl-penicillamine). Experiments were performed
without or with oxyhemoglobin to inhibit NO e#ects. Apoptosis was determined by the TUNEL method as
described in the Materials and methods section.
Results from duplicate experiments are expressed as the mean percentage of apoptotic cells&SD (N=5).Table II
Effects of endogenous NO on synoviocyte apoptosis
Treatment Nitrite
(ìmol/l)
% of
apoptotic cells
Control 1.2&0.8 <1
IL-1â 5.3&1.1* 2&1
TNF-Æ 2.8&0.3 4&2*
IFN-ª 1.9&0.4 <1
IL-1â+TNF-Æ+IFN-ª 11&2.6† 6&3*
IL-1â+TNF-Æ+IFN-ª+NMA 1.7&0.5 2&1
Cultured synovial cells from OA patients were treated with
the following cytokines, alone or in combination: IL-1â (1 ng/
ml), TNF-Æ (500 pg/ml), IFN-ª (104 IU/ml). NMA (N-methyl-
arginine) was used to inhibit the inducible NO synthase. Nitrite
in synoviocyte supernatants was measured by the Griess reac-
tion and apoptosis was determined by the TUNEL method as
described in the Materials and methods section.
Results from duplicate experiments are expressed as the mean
nitrite concentration&SD and as the mean percentage of
apoptotic cells&SD (N=5).
*P<0.01, †p<0.001 versus control cells.APOPTOSIS AFTER NO PRODUCTION
To assess if endogenous NO production by syn-
ovial cells was able to induce apoptosis, synovio-
cytes were treated with rhIL-1â (1 ng/ml) or a
combination of IL-1â (1 ng/ml), TNF-Æ (500 pg/ml)
and IFN-ª (104 IU/ml) for 24 hours). Conditioned
media were collected to measure nitrite concen-
trations. Only the combination of IL-1â, TNF-Æ and
Osteoarthritis and Cartilage Vol. 7 No. 2 209IFN-ª was able to increase nitrite in cell superna-
tants but induced fewer than 10% apoptotic cells
when analysed by both light microscopy and the
TUNEL method (Table II). The synthesis of NO
was inhibited when the cytokine combination was
co-incubated with NMA (P<0.01) (Table II).
EXPRESSION OF P53 PROTEIN IN SYNOVIOCYTES
Immunofluorescence experiments were per-
formed to determine the subcellular localization of
p53. Before NO donor treatment, we observed a
granular cytoplasmic labeling in the majority of
synovial cells (82&8% of cells); some synoviocytes
also showed a weak nuclear labeling (<10%). After
NO donor exposure, cells demonstrated a time and
dose-dependent nuclear staining with a parallel
decrease in the cytoplasmic labeling (Fig. 5).
Using double-labeling for p53 and the TUNEL
method, the majority of the strongly TUNEL-
positive cells also showed subnuclear positive
immunostaining for p53 protein (Fig. 6).
Discussion
Numerous studies have shown that NO is able to
induce apoptosis in a great number of cultured cell
types, such as murine peritoneal macrophages [8],
mouse thymocytes [9], or human chondrocytes [17].
Our results are the first to provide morphological
and biochemical characterization of NO-induced
cell apoptosis in human osteoarthritis synovio-
cytes. These data show evidence of cytoplasmic
events such as vacuolization and protuberances of
cell membranes that appear before DNA conden-
sation observed by the TUNEL method, propidium
iodide staining and flow cytometry analysis. Only
the high NO donor concentrations induced syn-
oviocyte apoptosis. However, apoptotic cells are
certainly underestimated under these conditions,
since some of the cells can detach from the dishes.
Moreover, the LDH activity measured in the
supernatants of treated cells was not significantly
di#erent from that of control cells, proving the
cytoplasmic membrane integrity of cells remaining
adherent (data not shown).
To assess the specific e#ect of the NO radical, we
treated cells with two chemically di#erent NO
donors. SNP requires electron transfer to release10000 800600400200
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Magnification #1000.NO radicals whereas SNAP releases NO spon-
taneously, but the observed results were similar.
Several mechanisms have been suggested to
explain NO induced apoptosis. In rat insulinoma
cells [28], it has been reported that high NO levels
induced mitochondrial damage associated with
DNA fragmentation and cell death. A more direct
mechanism for NO-mediated apoptosis is sug-
gested by the work of Nguen et al. [29] who dem-
onstrated that NO could deaminate purine and
pyrimidine bases in DNA and increase DNA strand
breaks.Several cell sources can produce NO in the OA
articular sites. Cultures of human chondrocytes
synthesize large amounts of NO in response to
IL-1â [30]. The chondrocyte NO synthase presents
close analogies with the brain isoform [31]. More
recently, Hayashi et al. [16] have shown that larger
amounts of NO may be produced by superficial
chondrocytes than by their deep counterparts,
showing the important role of NO at the cartilage-
synovial membrane interface. Even though NO is
limited by its short half life (4 sec) [32], this highly
di#usible radical can theoretically exert relatively
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FIG. 6. Co-expression of p53 and DNA strand breaks
in synovial cells. p53 expression was determined by
immunofluorescence using a polyclonal antibody and
DNA breaks were analyzed by the TUNEL method as
described in the Materials and methods section. Cells
were treated by SNP (1.25 mM). *P< 0.01 versus cells at
t0, ** P<0.001 versus cells at t0.References
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